Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Bachelier

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
International Journal of Cancer|February 6, 2020
Therapeutic targeting of soluble CD146/MCAM with the M2J-1 monoclonal antibody prevents metastasis development and procoagulant activity in CD146-positive invasive tumorsJimmy Stalin, Wael Traboulsi, Lucie Vivancos-Stalin, et al.
International Journal of Cancer|December 3, 2014
CD146 mediates VEGF-induced melanoma cell extravasation through FAK activationNathalie Jouve, Richard Bachelier, Nicolas Despoix, et al.
Journal of Molecular and Cellular Cardiology|April 1, 2019
CD146 deficiency promotes plaque formation in a mouse model of atherosclerosis by enhancing RANTES secretion and leukocyte recruitmentMuriel G Blin, Richard Bachelier, Karim Fallague, et al.
Cells|June 27, 2020
Multilineage Differentiation for Formation of Innervated Skeletal Muscle Fibers from Healthy and Diseased Human Pluripotent Stem CellsKilian Mazaleyrat, Cherif Badja, Natacha Broucqsault, et al.
Blood|February 13, 2014
Accelerated senescence of cord blood endothelial progenitor cells in premature neonates is driven by SIRT1 decreased expressionPaula Frizera Vassallo, Stéphanie Simoncini, Isabelle Ligi, et al.
Cardiovascular Research|May 13, 2016
Soluble CD146 boosts therapeutic effect of endothelial progenitors through proteolytic processing of short CD146 isoformJimmy Stalin, Karim Harhouri, Lucas Hubert, et al.
Acta Neuropathologica Communications|October 24, 2022
Soluble CD146, a biomarker and a target for preventing resistance to anti-angiogenic therapy in glioblastomaAhmad Joshkon, Emeline Tabouret, Wael Traboulsi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 10, 2022
Involvement of Multiple Variants of Soluble CD146 in Systemic Sclerosis: Identification of a Novel Profibrotic FactorMarie Nollet, Richard Bachelier, Ahmad Joshkon, et al.
Oncotarget|January 20, 2018
A novel anti-CD146 antibody specifically targets cancer cells by internalizing the moleculeMarie Nollet, Jimmy Stalin, Anaïs Moyon, et al.
The Journal of Investigative Dermatology|June 11, 2022
CD146 at the Interface between Oxidative Stress and the Wnt Signaling Pathway in Systemic SclerosisXavier Heim, Julien Bermudez, Ahmad Joshkon, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
International Journal of Cancer|February 6, 2020
Therapeutic targeting of soluble CD146/MCAM with the M2J-1 monoclonal antibody prevents metastasis development and procoagulant activity in CD146-positive invasive tumorsJimmy Stalin, Wael Traboulsi, Lucie Vivancos-Stalin, et al.
International Journal of Cancer|December 3, 2014
CD146 mediates VEGF-induced melanoma cell extravasation through FAK activationNathalie Jouve, Richard Bachelier, Nicolas Despoix, et al.
Journal of Molecular and Cellular Cardiology|April 1, 2019
CD146 deficiency promotes plaque formation in a mouse model of atherosclerosis by enhancing RANTES secretion and leukocyte recruitmentMuriel G Blin, Richard Bachelier, Karim Fallague, et al.
Cells|June 27, 2020
Multilineage Differentiation for Formation of Innervated Skeletal Muscle Fibers from Healthy and Diseased Human Pluripotent Stem CellsKilian Mazaleyrat, Cherif Badja, Natacha Broucqsault, et al.
Blood|February 13, 2014
Accelerated senescence of cord blood endothelial progenitor cells in premature neonates is driven by SIRT1 decreased expressionPaula Frizera Vassallo, Stéphanie Simoncini, Isabelle Ligi, et al.
Cardiovascular Research|May 13, 2016
Soluble CD146 boosts therapeutic effect of endothelial progenitors through proteolytic processing of short CD146 isoformJimmy Stalin, Karim Harhouri, Lucas Hubert, et al.
Acta Neuropathologica Communications|October 24, 2022
Soluble CD146, a biomarker and a target for preventing resistance to anti-angiogenic therapy in glioblastomaAhmad Joshkon, Emeline Tabouret, Wael Traboulsi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 10, 2022
Involvement of Multiple Variants of Soluble CD146 in Systemic Sclerosis: Identification of a Novel Profibrotic FactorMarie Nollet, Richard Bachelier, Ahmad Joshkon, et al.
Oncotarget|January 20, 2018
A novel anti-CD146 antibody specifically targets cancer cells by internalizing the moleculeMarie Nollet, Jimmy Stalin, Anaïs Moyon, et al.
The Journal of Investigative Dermatology|June 11, 2022
CD146 at the Interface between Oxidative Stress and the Wnt Signaling Pathway in Systemic SclerosisXavier Heim, Julien Bermudez, Ahmad Joshkon, et al.
Pageof 4